lamotrigine has been researched along with Vomiting in 5 studies
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate and compare the effects of concomitant lamotrigine (LTG) or carbamazepine (CBZ) on the incidence of treatment-emergent adverse events (TEAEs) in patients taking adjunctive eslicarbazepine acetate (ESL) for focal (partial-onset) seizures (FS)." | 9.27 | Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. ( Abou-Khalil, B; Blum, D; Cheng, H; Gama, H; Grinnell, T; Jung, J; Klein, P; Rocha, F; Ryvlin, P; Shah, A; Specchio, LM, 2018) |
| "To compare the pharmacokinetics (PK) of lamotrigine (LTG) when converting from twice-daily immediate-release (LTG-IR) to once-daily extended-release (LTG-XR) in subjects with epilepsy." | 9.13 | Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study). ( Ali, I; Hammer, AE; Job, S; Lemme, F; Messenheimer, JA; Oliver-Willwong, R; Tompson, DJ; Vuong, A; Zhu, L, 2008) |
| "The purpose of this case series is to characterize a recently identified association of the antiepileptic drug (AED) lamotrigine with aseptic meningitis based on cases reported to the Food and Drug Administration (FDA)'s Adverse Event Reporting System (AERS) database." | 7.78 | Lamotrigine and aseptic meningitis. ( Avigan, M; Kortepeter, C; Simms, KM, 2012) |
| "To evaluate and compare the effects of concomitant lamotrigine (LTG) or carbamazepine (CBZ) on the incidence of treatment-emergent adverse events (TEAEs) in patients taking adjunctive eslicarbazepine acetate (ESL) for focal (partial-onset) seizures (FS)." | 5.27 | Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. ( Abou-Khalil, B; Blum, D; Cheng, H; Gama, H; Grinnell, T; Jung, J; Klein, P; Rocha, F; Ryvlin, P; Shah, A; Specchio, LM, 2018) |
| "To compare the pharmacokinetics (PK) of lamotrigine (LTG) when converting from twice-daily immediate-release (LTG-IR) to once-daily extended-release (LTG-XR) in subjects with epilepsy." | 5.13 | Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study). ( Ali, I; Hammer, AE; Job, S; Lemme, F; Messenheimer, JA; Oliver-Willwong, R; Tompson, DJ; Vuong, A; Zhu, L, 2008) |
| "The purpose of this case series is to characterize a recently identified association of the antiepileptic drug (AED) lamotrigine with aseptic meningitis based on cases reported to the Food and Drug Administration (FDA)'s Adverse Event Reporting System (AERS) database." | 3.78 | Lamotrigine and aseptic meningitis. ( Avigan, M; Kortepeter, C; Simms, KM, 2012) |
| "Lamotrigine was effective for the adjunctive treatment of partial seizures in children and demonstrated an acceptable safety profile." | 2.69 | A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. ( Billard, C; Casale, E; Duchowny, M; Gilman, J; Graf, WD; Manasco, P; Pellock, JM; Risner, M; Womble, G, 1999) |
| "To identify adverse drug reactions associated with lamotrigine in children and compare the safety profile with other antiepileptic drugs." | 2.52 | Safety of lamotrigine in paediatrics: a systematic review. ( Choonara, I; Egunsola, O; Sammons, HM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Khalil, B | 1 |
| Klein, P | 1 |
| Shah, A | 1 |
| Ryvlin, P | 1 |
| Specchio, LM | 1 |
| Gama, H | 1 |
| Rocha, F | 1 |
| Blum, D | 1 |
| Grinnell, T | 1 |
| Cheng, H | 1 |
| Jung, J | 1 |
| Egunsola, O | 1 |
| Choonara, I | 1 |
| Sammons, HM | 1 |
| Simms, KM | 1 |
| Kortepeter, C | 1 |
| Avigan, M | 1 |
| Tompson, DJ | 1 |
| Ali, I | 1 |
| Oliver-Willwong, R | 1 |
| Job, S | 1 |
| Zhu, L | 1 |
| Lemme, F | 1 |
| Hammer, AE | 1 |
| Vuong, A | 1 |
| Messenheimer, JA | 1 |
| Duchowny, M | 1 |
| Pellock, JM | 1 |
| Graf, WD | 1 |
| Billard, C | 1 |
| Gilman, J | 1 |
| Casale, E | 1 |
| Womble, G | 1 |
| Risner, M | 1 |
| Manasco, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa[NCT00264615] | Phase 3 | 45 participants | Interventional | 2005-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lamotrigine and Vomiting
| Article | Year |
|---|---|
Safety of lamotrigine in paediatrics: a systematic review.
Topics: Abdominal Pain; Anticonvulsants; Child; Dizziness; Drug Therapy, Combination; Exanthema; Headache; H | 2015 |
3 trials available for lamotrigine and Vomiting
| Article | Year |
|---|---|
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Diplopia; Dose-Response Re | 2018 |
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Area Under Curve; | 2008 |
A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind | 1999 |
1 other study available for lamotrigine and Vomiting
| Article | Year |
|---|---|
Lamotrigine and aseptic meningitis.
Topics: Adolescent; Adult; Aged; Algorithms; Animals; Anticonvulsants; Antidepressive Agents; Bipolar Disord | 2012 |